nemonapride

This page covers all nemonapride drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(4) dopamine receptor, Transmembrane protein 97, D(2) dopamine receptor.

Targets

D(4) dopamine receptor, Transmembrane protein 97, D(2) dopamine receptor

Phase 2 pipeline (1)

• Emonapride · Neuroscience
  Emonapride works by blocking the D(4) dopamine receptor, which can help to reduce excessive dopamine activity in the brain.

Patent intelligence

• nemonapride patent landscape — aggregated cliff calendar, attackable patents, originator estates